Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1995
12/20/1995EP0687472A2 Potentiation of drug response by a serotonin 1A receptor antagonist
12/20/1995EP0687467A2 Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients
12/20/1995EP0180581B2 Drug preparations of reduced toxicity
12/20/1995CN1113647A Heart function restorative
12/20/1995CN1113436A Potentiation of drug response
12/19/1995US5476669 Administering a bismuth compound, a first antibiotic from tetracycline and penicillin groups and a second antibiotic which is metronidazole; for preventing recurrence of duodenal ulcer
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033464A2 Retroviral protease inhibitor combinations
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995WO1995033453A1 Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites
12/14/1995DE4420102A1 Combination prepns. contg. alpha-liponic acid or its metabolites
12/14/1995DE4419814A1 Endoparasitizide Endoparasiticides
12/14/1995CA2192061A1 Uterine fibroid treatment
12/14/1995CA2191948A1 Retroviral protease inhibitor combinations
12/13/1995EP0686042A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
12/13/1995EP0686037A1 Hormone replacement therapy
12/12/1995US5475004 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
12/12/1995US5474990 Preventing brain damage from hypoxia/ischemia caused by stroke, cardiac arrest
12/12/1995US5474985 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
12/12/1995US5474978 Insulin analog formulations
12/07/1995WO1995033060A1 Method of cancer treatment by p53 protein control
12/07/1995WO1995032982A1 Dna encoding gls1
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995WO1995032707A1 Medicinal film for the treatment of periodontitis
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2191067A1 Dna encoding gls1
12/06/1995EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta
12/06/1995EP0684829A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof
12/06/1995EP0684823A1 Fibrinogen receptor antagonists
12/06/1995EP0684817A1 Cancer treatment
12/06/1995EP0684816A1 5-ht 2? receptor antagonist compositions useful in treating venous conditions
12/06/1995EP0500847B1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995EP0429542B1 Leukocyte adhesion inhibitor
12/06/1995CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound
12/05/1995US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/05/1995US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
12/05/1995US5472943 Co-administering agonist and antagonist
12/05/1995US5472712 A drug substrate containing an active agent coated with ethyl cellulose being cured at a temperature greater than the glass transition temperature; storage stability, sustained release
11/1995
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995031988A1 COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995031966A1 Antimicrobial oil-in-water emulsions
11/30/1995WO1995031956A1 Antibacterial oil-in-water emulsions
11/30/1995CA2190606A1 Antimicrobial oil-in-water emulsions
11/30/1995CA2190604A1 Antibacterial oil-in-water emulsions
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/29/1995EP0683665A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use
11/29/1995EP0683662A1 Waterproof cosmetic or dermatological photoprotective preparations
11/29/1995EP0683661A1 Cosmetic and dermatological photoprotective formulations containing inorganic micro-pigments.
11/29/1995EP0586523A4 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/28/1995US5470880 Method of using citric acid for the treatment of wrinkles
11/28/1995US5470847 Contraceptives by inhibiting ovulation
11/28/1995US5470838 Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
11/28/1995US5470577 Stimulation of tanning by DNA fragments or single-stranded DNA
11/27/1995CA2124396A1 Chemical compounds
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031479A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995WO1995031194A1 Compositions for treatment of chronic inflammatory diseases
11/23/1995WO1995029257A3 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995DE4417254A1 Lignin based products for use in veterinary medicine or animal hygiene
11/23/1995CA2190502A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995CA2190107A1 Compositions for treatment of chronic inflammatory diseases
11/22/1995EP0682869A1 Non-systemic control of parasites
11/22/1995EP0682520A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases
11/22/1995EP0682516A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors
11/22/1995EP0682514A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
11/21/1995US5468764 Administering to a mammal an azole derivative
11/21/1995US5468757 For treating stroke or myocardial infarction in humans
11/21/1995US5468755 Therapeutic process for the treatment of the pathologies of Type II diabetes
11/21/1995US5468736 Hormone replacement therapy
11/21/1995US5468505 Local delivery of fibrinolysis enhancing agents
11/21/1995CA1337591C Therapeutic composition comprising oestrogen and antioestrogen
11/16/1995WO1995030431A1 Method for reduction of headache pain
11/16/1995WO1995030423A2 Cancer treatment and metastasis prevention
11/16/1995WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995WO1995030408A1 Occlusive dressings
11/16/1995CA2312047A1 Method for reduction of headache pain
11/16/1995CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0489096B1 Pharmaceutical compositions and a device for administering the same
11/15/1995CN1111506A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
11/14/1995US5466696 Tacrine and cytochrome P450 oxidase inhibitors and methods of use
11/14/1995US5466680 Wound healing agents and metabolism
11/14/1995US5466667 Prophylactic and therapeutic methods for treating edema with antamanides
11/09/1995WO1995029683A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis
11/09/1995WO1995029680A1 New method of treatment
11/09/1995WO1995029674A1 A method of modifying angiotensin receptor activity for treatment of premenstrual syndrome and mediation of pain
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995WO1995029665A1 Effective dosage form for antiepileptic drugs
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/09/1995WO1995024896A3 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 1151